Kevan Shokat is a professor and a co-chair of the Department of Cellular and Molecular Pharmacology at the University of California at San Francisco and Professor of Chemistry at the University of California at Berkeley. He is also an investigator of the Howard Hughes Medical Institute.
Professor Shokat is a pioneer in the development of chemical methods for investigating cellular signal transduction pathways—with a particular focus on protein kinases and lipid kinases. His laboratory uses a combination of chemical synthesis and protein engineering to create uniquely traceable and regulatable kinases, allowing the function of more than 100 different kinases to be uncovered across all disease areas including oncology, metabolism, and infectious disease. Professor Shokat has received numerous awards for his work, including being named a Fellow of the Pew Foundation, Searle Foundation, Sloan Foundation, Glaxo-Wellcome Foundation, and the Cotrell Foundation. He has also received the Eli Lilly Award, given to the most promising biological chemist in the country under the age of 37. Professor Shokat is active in the development and commercialization of inventions made in his laboratory. He is a co-founder of Cellular Genomics, Inc., a company focused in New Haven, Connecticut, as well as a member of several other Scientific Advisory Boards including the Scientific Advisor Network of the DDS of Invitrogen Corporation and the Scientific Research Board of Genentech. He is also a co-founder of San Diego-based Intellikine.